Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Corporate Results

Profit or loss trends for various companies

 
Dr Reddy's Laboratories consolidated net profit rises 21.64% in the March 2025 quarter
09-May-25 17:18Hrs IST

Net profit of Dr Reddy's Laboratories rose 21.64% to Rs 1593.30 crore in the quarter ended March 2025 as against Rs 1309.80 crore during the previous quarter ended March 2024. Sales rose 20.09% to Rs 8506.00 crore in the quarter ended March 2025 as against Rs 7083.00 crore during the previous quarter ended March 2024.

For the full year,net profit rose 1.38% to Rs 5655.10 crore in the year ended March 2025 as against Rs 5577.90 crore during the previous year ended March 2024. Sales rose 16.61% to Rs 32553.50 crore in the year ended March 2025 as against Rs 27916.40 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales8506.007083.00 20 32553.5027916.40 17
OPM %23.4925.85 -26.2628.42 -
PBDT2459.901972.90 25 9383.208671.00 8
PBT2005.201605.20 25 7679.507201.00 7
NP1593.301309.80 22 5655.105577.90 1

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise